Cambridge Cognition buys vocal biomarker firm Winterlight
pharmaphorum
JANUARY 17, 2023
UK digital brain health company Cambridge Cognition has bolstered its speech analysis capabilities with the acquisition of Winterlight Labs of Toronto, Canada, in a cash and stock deal worth £7 million ($8.6 million) to its top-line in 2023 with “considerable growth” next year.
Let's personalize your content